Inventor · disambiguated record
James Marvin Veal
Also filed as: VEAL JAMES · VEAL JAMES M · VEAL JAMES MARVIN
106 granted patents·33 pending applications·1,135 citations·filing 1998–2024
99Inventor score
Files withCELGENE QUANTICEL RES INC68QUANTICEL PHARMACEUTICALS INC16SMITHKLINE BEECHAM CORP10SERENEX INC7HUANG KENNETH H6
Top patents by PatentIndex Score
139 records- 0198US9255097B2Inhibitors of lysine specific demethylase-1QUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Feb 9, 2016·29 cites·30 claims
- 0297US9447045B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Sep 20, 2016·20 cites·16 claims
- 0397US6369086B1Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 1999·Granted Apr 9, 2002·213 cites·18 claims
- 0496US11084793B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2020·Granted Aug 10, 2021·3 cites·24 claims
- 0596US9573930B2Inhibitors of lysine specific demethylase-1QUANTICEL PHARMACEUTICALS INC·Filed 2016·Granted Feb 21, 2017·15 cites·16 claims
- 0696US8987461B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2013·Granted Mar 24, 2015·13 cites·21 claims
- 0796US8952151B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2013·Granted Feb 10, 2015·21 cites·18 claims
- 0896US6815439B2Substituted aza-oxindole derivativesSMITHKLINE BEECHAM CORP·Filed 2003·Granted Nov 9, 2004·53 cites·23 claims
- 0996US6268391B1Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinasesGLAXO WELLCOME INC·Filed 1998·Granted Jul 31, 2001·238 cites·26 claims
- 1095US9643965B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted May 9, 2017·6 cites·5 claims
- 1195US7678803B2Quinazoline derivatives for the treatment of cancerSERENEX INC·Filed 2007·Granted Mar 16, 2010·97 cites·46 claims
- 1295US7105529B2Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effectsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Sep 12, 2006·64 cites·5 claims
- 1394US11535616B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Dec 27, 2022·2 cites·13 claims
- 1494US9034900B2Bromodomain inhibitorsQuanticel Pharmaceuticals·Filed 2014·Granted May 19, 2015·36 cites·30 claims
- 1594US7262203B2Pyrimidineamines as angiogenesis modulatorsSMITHKLINE BEECHAM CORP·Filed 2006·Granted Aug 28, 2007·32 cites·50 claims
- 1693US10316016B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2018·Granted Jun 11, 2019·4 cites·8 claims
- 1793US10112940B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Oct 30, 2018·4 cites·6 claims
- 1893US9085534B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Jul 21, 2015·8 cites·34 claims
- 1992US10815234B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Oct 27, 2020·2 cites·9 claims
- 2092US10208039B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Feb 19, 2019·4 cites·8 claims
- 2192US10202381B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Feb 12, 2019·4 cites·24 claims
- 2292US10047069B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Aug 14, 2018·4 cites·3 claims
- 2392US9107916B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Aug 18, 2015·4 cites·38 claims
- 2492US7358370B2Benzene, pyridine, and pyridazine derivativesSERENEX INC·Filed 2006·Granted Apr 15, 2008·21 cites·30 claims
- 2591US11702428B2Chemical compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2022·Granted Jul 18, 2023·1 cites·24 claims
- 2691US10030017B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Jul 24, 2018·4 cites·4 claims
- 2791US9771329B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2016·Granted Sep 26, 2017·6 cites·19 claims
- 2891US9133166B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2014·Granted Sep 15, 2015·10 cites·17 claims
- 2991US8114885B2Chemical compoundsBOLOOR AMOGH·Filed 2007·Granted Feb 14, 2012·22 cites·19 claims
- 3090US10703739B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2019·Granted Jul 7, 2020·2 cites·11 claims
- 3190US10654810B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2018·Granted May 19, 2020·2 cites·19 claims
- 3290US10023543B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Jul 17, 2018·4 cites·2 claims
- 3390US2025066355A1Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2024·Application pending·0 cites
- 3489US10611763B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Apr 7, 2020·2 cites·7 claims
- 3589US9776974B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Oct 3, 2017·4 cites·19 claims
- 3688US11214542B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Jan 4, 2022·1 cites·17 claims
- 3788US11040985B2Chemical compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2019·Granted Jun 22, 2021·3 cites·74 claims
- 3888US9828358B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2016·Granted Nov 28, 2017·5 cites·20 claims
- 3988US7928135B2Benzene, pyridine, and pyridazine derivativesSERENEX INC·Filed 2010·Granted Apr 19, 2011·8 cites·4 claims
- 4087US8969343B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2013·Granted Mar 3, 2015·3 cites·21 claims
- 4187US7906529B2Benzene, pyridine, and pyridazine derivativesSERENEX INC·Filed 2007·Granted Mar 15, 2011·7 cites·8 claims
- 4287US6541503B2Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Apr 1, 2003·22 cites·17 claims
- 4387US2023286917A1Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2023·Application pending·0 cites
- 4486US10807956B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Oct 20, 2020·1 cites·18 claims
- 4586US10207999B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Feb 19, 2019·2 cites·2 claims
- 4686US9676770B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Jun 13, 2017·5 cites·15 claims
- 4785US12172998B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2022·Granted Dec 24, 2024·0 cites·13 claims
- 4885US11939335B2Substituted imidazo[1,2-a]quinazolines and imidazo [1,2-a]pyrido[4,3-e]pyrimidines as inhibitors of PARG858 THERAPEUTICS INC·Filed 2023·Granted Mar 26, 2024·1 cites·28 claims
- 4985US10870634B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Dec 22, 2020·1 cites·11 claims
- 5085US10807982B2Bromodomain inhibitorsCELGENE QUANTICEL RES INC·Filed 2019·Granted Oct 20, 2020·2 cites·14 claims
Showing the top 50 of 139 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James Marvin Veal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →